%0 Journal Article
%T Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome
%A Amarnath Sharma
%A Anne Hermanowski-Vosatka
%A Dirk Garmann
%A Gary Peters
%A Jeffrey I. Weitz
%A Keith A. A. Fox
%A Liping Zhang
%A Partha Nandy
%A Scott D. Berkowitz
%A Stefan Willmann
%A Stephan Schmidt
%A Xiaoyu Yan
%J Archive of "Therapeutic Advances in Cardiovascular Disease".
%D 2019
%R 10.1177/1753944719863641
%X This analysis aimed to evaluate the impact of rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome (ACS) and to determine whether therapeutic drug monitoring might provide additional information regarding rivaroxaban dose, beyond what patient characteristics provide
%K acute coronary syndromes
%K bleeding
%K exposure¨Cresponse analysis
%K monitoring
%K population pharmacokinetics
%K rivaroxaban
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669848/